Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ViraCor/IBT Laboratories merge

This article was originally published in The Gray Sheet

Executive Summary

Privately-held providers of testing and clinical trial services agree to merge for undisclosed terms, creating a "new specialty diagnostics laboratory," they announce June 30. ViraCor Laboratories President John Martin, who will also serve as president of the new firm, said the merger "gives ViraCor and IBT the combined scientific know-how and national network not only to reach additional customers who could benefit from our current test menu, but also to expand our services." ViraCor, based in Lee's Summit, Mo., specializes in molecular diagnostic testing for infectious diseases. Lenexa, Ks.-based IBT focuses on immunology and allergy testing. Both companies will continue to operate their respective facilities

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027641

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel